COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,760 Articles (22,502 medRxiv, 8,258 bioRxiv)

Most recent first Previous |  Page 2222: Articles 22211-22220  | Next

The impact of COVID-19 on the lives and mental health of Australian adolescents
Li, S., Beames, J., Newby, J., Maston, K., Christensen, H., Werner-Seidler, A.
10.1101/2020.09.07.20190124 — Posted: 2020-09-09
COVID-19 in patients with hepatobiliary and pancreatic diseases in East London: A single-centre cohort study
Dayem Ullah, A. Z. M., Sivapalan, L., Chelala, C., Kocher, H. M.
10.1101/2020.09.07.20189621 — Posted: 2020-09-09
Seroprevalence of the SARS-CoV-2 infection in health workers of the Sanitary Region VIII, at province of Buenos Aires
Silva, A., Aguirre, M. F., Ballejo, C., Marro, M. J., GAMARNIK, A., Vargas, G., Pifano, M., Varela, T., Garcia, E., Lawrynowicz, A., Uez, O., Pagano, I.
10.1101/2020.09.07.20189050 — Posted: 2020-09-09
First report on the Latvian SARS-CoV-2 isolate genetic diversity
Zrelovs, N., Ustinova, M., Silamikelis, I., Birzniece, L., Megnis, K., Rovite, V., Freimane, L., Silamikele, L., Ansone, L., Pjalkovskis, J., Fridmanis, D., Priedite, M., Caica, A., Gavars, M., Perminovs, D., Storozenko, J., Savicka, O., Dimina, E., Dumpis, U., Klovins, J.
10.1101/2020.09.08.20190504 — Posted: 2020-09-09
Influenza may facilitate the spread of SARS-CoV-2
Domenech de Celles, M., Casalegno, J.-S., Lina, B., Opatowski, L.
10.1101/2020.09.07.20189779 — Posted: 2020-09-09 Discussion: Onsite
Covid-19 Belgium: Extended SEIR-QD model with nursery homes and long-term scenarios-based forecasts from school opening
Franco, N.
10.1101/2020.09.07.20190108 — Posted: 2020-09-09
Passive, open access data measures movement and predicts COVID-19 cases
Faust, C. L., Lambert, B., Kochenour, C., Robinson, A. C., Bharti, N.
10.1101/2020.09.09.20190389 — Posted: 2020-09-09
Tracking Smell Loss to Identify Healthcare Workers with SARS-CoV-2 Infection
Weiss, J. J., Attuquayefio, T. N., White, E. B., Li, F., Herz, R. S., White, T. L., Campbell, M., Geng, B., Datta, R., Wyllie, A. L., Grubaugh, N. D., Casanovas-Massana, A., Muenker, M. C., Handoko, R., Iwasaki, A., The Yale IMPACT Research Team, , Martinello, R. A., Ko, A. I., Small, D. M., Farhadian, S. F.
10.1101/2020.09.07.20188813 — Posted: 2020-09-09
Understanding SARSCOV-2 propagation, impacting factors to derive possible scenarios and simulations
Mehl-Madrona, L. E., Bricaire, F., Cuyugan, A., Barac, J., Parvaiz, A., Jamil, A. B., Iqbal, S., Sellier, M. K.
10.1101/2020.09.07.20190066 — Posted: 2020-09-09 Discussion: Onsite
Insufficient hyperfibrinolysis in COVID-19: a systematic review of thrombolysis based on meta-analysis and meta-regression
Ji, H.-L. J., Su, Z., Zhao, R., Komissarov, A. A., Yi, G., Liu, S.-L., Idell, S., Matthay, M. A.
10.1101/2020.09.07.20190165 — Posted: 2020-09-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).